[Hepatoxic side-effects of rifampicin. A comparative clinical study].
D000410:Alanine Transaminase / Q000097:blood; D000437:Alcoholism / Q000150:complications; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy
D004977:Ethambutol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Hepatotoxische Nebenwirkungen von Rifampicin.